搜尋結果
2022年3月30日 · Background. The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19...
2022年12月14日 · To the Editor: Reis et al. (May 5 issue)1 present the results of the TOGETHER platform trial, a large trial of ivermectin in outpatients with Covid-19. The relative risk of hospitalization or...
2023年12月20日 · The safety and efficacy of ivermectin for the prevention and treatment of COVID-19 have been evaluated in clinical trials and observational cohorts. Summaries of the studies that informed the COVID-19 Treatment Guidelines Panel’s (the Panel) recommendation can be found in Table 7b.
2021年8月17日 · 伊維菌素 (Ivermectin) 對 COVID-19 感染症是否有效？. 關鍵資訊. 我們沒有發現任何證據表示使用伊維菌素能有效治療或預防 COVID-19 感染症。. 此佐證資料仍持續更新中，但證據仍然有限。. 目前仍有 31 項針對伊維菌素的研究在進行中，我們將在其得出結論後更新本 ...
2022年8月17日 · Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes, Journal of Infection, 88, 4, (106130...
2021年6月15日 週二 上午11:07 ·7 分鐘. 近來《美國治療學期刊（American Journal of Therapeutics）》一篇評論指出，口服抗寄生蟲藥物「伊維菌素（ Ivermectin）」有機會預防新冠病毒感染，且能縮短新冠病人的恢復期、降低死亡率。. 這般訊息令人眼睛為之一亮，但證據 ...
2021年6月21日 · For trials of COVID-19 treatment, 16 evaluated ivermectin among participants with mild to moderate COVID-19 only; 6 trials included patients with severe COVID-19. Most compared ivermectin with placebo or no ivermectin; 3 trials included an active comparator 1
